SIG-012

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSIG-012
Drug Alias Nameendocrine/chronic disorders Cell therapy (Sigilon Therapeutics)SIG-012
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEndocrine System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSigilon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigilon Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsEndocrine System Diseases

Other Information

ATC CodeN/A
Related LinksN/A